Nepafenac
Non-steroidal anti-inflammatory drug
Nepafenac | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Nepafenac is a non-steroidal anti-inflammatory drug (NSAID) used in ophthalmology to manage pain and inflammation associated with cataract surgery. It is a prodrug that is converted to amfenac in the eye, which then exerts its therapeutic effects.
Mechanism of Action[edit | edit source]
Nepafenac is a prodrug that, upon instillation into the eye, is rapidly converted by intraocular hydrolases to its active form, amfenac. Amfenac inhibits the activity of cyclooxygenase (COX-1 and COX-2) enzymes, which are responsible for the conversion of arachidonic acid to prostaglandins. Prostaglandins are mediators of inflammation and pain, and their inhibition leads to reduced inflammation and analgesia.
Clinical Use[edit | edit source]
Nepafenac is primarily indicated for the treatment of pain and inflammation associated with cataract surgery. It is administered as an ophthalmic suspension and is typically used in the perioperative period to manage postoperative inflammation and reduce the risk of cystoid macular edema.
Dosage and Administration[edit | edit source]
Nepafenac is available as a 0.1% ophthalmic suspension. The recommended dosage is one drop applied to the affected eye(s) three times daily, beginning one day prior to cataract surgery, and continued on the day of surgery and through the first two weeks of the postoperative period.
Side Effects[edit | edit source]
Common side effects of nepafenac include eye pain, ocular irritation, and conjunctival hyperemia. Less common but more serious side effects can include corneal thinning, corneal erosion, and delayed healing. Patients should be monitored for signs of corneal complications, especially if they are using other topical ophthalmic medications.
Contraindications and Precautions[edit | edit source]
Nepafenac is contraindicated in patients with known hypersensitivity to nepafenac, amfenac, or any other components of the formulation. Caution is advised in patients with a history of herpetic keratitis or other corneal conditions. It should be used with caution in patients with bleeding tendencies or those on anticoagulant therapy, as NSAIDs can increase the risk of bleeding.
Pharmacokinetics[edit | edit source]
After topical ocular administration, nepafenac is rapidly absorbed and converted to amfenac in the eye. The systemic exposure to nepafenac and amfenac is low, minimizing the risk of systemic side effects. The elimination half-life of amfenac in the aqueous humor is approximately 1.7 hours.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD